130 related articles for article (PubMed ID: 12704574)
21. Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.
Wen Y; Shah S; Campbell KN
Front Med (Lausanne); 2018; 5():98. PubMed ID: 29713631
[TBL] [Abstract][Full Text] [Related]
22. MAGI-1 Interacts with Nephrin to Maintain Slit Diaphragm Structure through Enhanced Rap1 Activation in Podocytes.
Ni J; Bao S; Johnson RI; Zhu B; Li J; Vadaparampil J; Smith CM; Campbell KN; Grahammer F; Huber TB; He JC; D'Agati VD; Chan A; Kaufman L
J Biol Chem; 2016 Nov; 291(47):24406-24417. PubMed ID: 27707879
[TBL] [Abstract][Full Text] [Related]
23. Practical Application of Columbia Classification for Focal Segmental Glomerulosclerosis.
Han MH; Kim YJ
Biomed Res Int; 2016; 2016():9375753. PubMed ID: 27247945
[TBL] [Abstract][Full Text] [Related]
24. Podocytes.
Reiser J; Altintas MM
F1000Res; 2016; 5():. PubMed ID: 26918173
[TBL] [Abstract][Full Text] [Related]
25. A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.
Yu H; Artomov M; Brähler S; Stander MC; Shamsan G; Sampson MG; White JM; Kretzler M; Miner JH; Jain S; Winkler CA; Mitra RD; Kopp JB; Daly MJ; Shaw AS
J Clin Invest; 2016 Mar; 126(3):1067-78. PubMed ID: 26901816
[TBL] [Abstract][Full Text] [Related]
26. Circulating CD40 autoantibody and suPAR synergy drives glomerular injury.
Wei C; Sigdel TK; Sarwal MM; Reiser J
Ann Transl Med; 2015 Nov; 3(19):300. PubMed ID: 26697460
[No Abstract] [Full Text] [Related]
27. Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.
Alfano M; Cinque P; Giusti G; Proietti S; Nebuloni M; Danese S; D'Alessio S; Genua M; Portale F; Lo Porto M; Singhal PC; Rastaldi MP; Saleem MA; Mavilio D; Mikulak J
Sci Rep; 2015 Sep; 5():13647. PubMed ID: 26380915
[TBL] [Abstract][Full Text] [Related]
28. Causes and pathogenesis of focal segmental glomerulosclerosis.
Fogo AB
Nat Rev Nephrol; 2015 Feb; 11(2):76-87. PubMed ID: 25447132
[TBL] [Abstract][Full Text] [Related]
29. Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.
Kawakami T; Gomez IG; Ren S; Hudkins K; Roach A; Alpers CE; Shankland SJ; D'Agati VD; Duffield JS
J Am Soc Nephrol; 2015 May; 26(5):1040-52. PubMed ID: 25406339
[TBL] [Abstract][Full Text] [Related]
30. Can biomarkers of disease activity guide treatment in FSGS?
Campbell KN; He JC
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1507-9. PubMed ID: 25107950
[No Abstract] [Full Text] [Related]
31. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease.
George B; Verma R; Soofi AA; Garg P; Zhang J; Park TJ; Giardino L; Ryzhova L; Johnstone DB; Wong H; Nihalani D; Salant DJ; Hanks SK; Curran T; Rastaldi MP; Holzman LB
J Clin Invest; 2012 Feb; 122(2):674-92. PubMed ID: 22251701
[TBL] [Abstract][Full Text] [Related]
32. Genetic diagnosis in consanguineous families with kidney disease by homozygosity mapping coupled with whole-exome sequencing.
Al-Romaih KI; Genovese G; Al-Mojalli H; Al-Othman S; Al-Manea H; Al-Suleiman M; Al-Jondubi M; Atallah N; Al-Rodayyan M; Weins A; Pollak MR; Adra CN
Am J Kidney Dis; 2011 Aug; 58(2):186-95. PubMed ID: 21658830
[TBL] [Abstract][Full Text] [Related]
33. Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design.
Trachtman H; Vento S; Gipson D; Wickman L; Gassman J; Joy M; Savin V; Somers M; Pinsk M; Greene T
BMC Nephrol; 2011 Feb; 12():8. PubMed ID: 21310077
[TBL] [Abstract][Full Text] [Related]
34. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of the homophilic adhesion molecule sidekick-1 in podocytes contributes to glomerulosclerosis.
Kaufman L; Potla U; Coleman S; Dikiy S; Hata Y; Kurihara H; He JC; D'Agati VD; Klotman PE
J Biol Chem; 2010 Aug; 285(33):25677-85. PubMed ID: 20562105
[TBL] [Abstract][Full Text] [Related]
36. Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture.
Garg P; Verma R; Cook L; Soofi A; Venkatareddy M; George B; Mizuno K; Gurniak C; Witke W; Holzman LB
J Biol Chem; 2010 Jul; 285(29):22676-88. PubMed ID: 20472933
[TBL] [Abstract][Full Text] [Related]
37. Induction of T regulatory cells attenuates idiopathic nephrotic syndrome.
Le Berre L; Bruneau S; Naulet J; Renaudin K; Buzelin F; Usal C; Smit H; Condamine T; Soulillou JP; Dantal J
J Am Soc Nephrol; 2009 Jan; 20(1):57-67. PubMed ID: 19020006
[TBL] [Abstract][Full Text] [Related]
38. Monozygotic transplantation: concerns and opportunities.
Krishnan N; Buchanan PM; Dzebisashvili N; Xiao H; Schnitzler MA; Brennan DC
Am J Transplant; 2008 Nov; 8(11):2343-51. PubMed ID: 18808409
[TBL] [Abstract][Full Text] [Related]
39. NPHS2 variation in sporadic focal segmental glomerulosclerosis.
McKenzie LM; Hendrickson SL; Briggs WA; Dart RA; Korbet SM; Mokrzycki MH; Kimmel PL; Ahuja TS; Berns JS; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Cho M; Zhou YC; Binns-Roemer E; Kirk GD; Kopp JB; Winkler CA
J Am Soc Nephrol; 2007 Nov; 18(11):2987-95. PubMed ID: 17942957
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic approach to FSGS in children.
Gipson DS; Gibson K; Gipson PE; Watkins S; Moxey-Mims M
Pediatr Nephrol; 2007 Jan; 22(1):28-36. PubMed ID: 17109140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
